Identifying mechanisms driving the early response of triple negative breast cancer patients to neoadjuvant chemotherapy using a mechanistic model integrating in vitro and in vivo imaging data. (arXiv:2212.04270v1 [q-bio.TO]) http://arxiv.org/abs/2212.04270